Paul Workman PhD, FRS, FRSC, FMedSci

Professor Paul Workman is the Chief Executive and President of The Institute of Cancer Research, London. He leads a team in the Division of Cancer Therapeutics which is carrying out pioneering work to discover new drugs to treat cancer and understand how cancer drugs work.

Professor Workman completed his BSc in Biochemistry at the University of Leicester UK (1973) and his Ph.D. in Cancer Pharmacology at the University of Leeds UK (1977). In 1976 he moved to the Medical Research Council's Clinical Oncology Unit in the MRC Centre, the University of Cambridge UK where he established a preclinical and clinical cancer pharmacology laboratory. He developed his early career in Cambridge from 1976 to 1990, focusing mainly on drugs designed to exploit tumor hypoxia and contributing to the discovery and clinical development of several hypoxia-targeted agents, leading to a tenured professorial level appointment.